Innate Pharma S.A.
IPHA · NASDAQ
Filings10
Total reported value$137.9K
| Manager | Shares | Value | Change |
|---|---|---|---|
| MORGAN STANLEY | 53.6K | $90.5K | +4.2% |
| CITADEL ADVISORS LLC | 20K | $33.9K | -48.8% |
| UBS Group AG | 4.8K | $8.1K | -31.9% |
| GAMMA Investing LLC | 2.3K | $3.9K | -106.2% |
| RHUMBLINE ADVISERS | 470 | $794.3 | 0.0% |
| BARCLAYS PLC | 307 | $518.8 | 0.0% |
| Optiver Holding B.V. | 101 | $170.7 | 0.0% |
| PRINCIPAL SECURITIES, INC. | 45 | $76.1 | 0.0% |
| Farther Finance Advisors, LLC | 10 | $16.9 | +50.0% |
| MILLENNIUM MANAGEMENT LLC | 0 | $0.0 | +100.0% |